Episode release date: 04/16/2026 12pm ET
Kratom products have rapidly evolved from traditional plant forms into highly potent semi-synthetic compounds now widely available in retail settings. This shift has introduced new risks, including use disorder, severe withdrawal, and overdose, while outpacing clinical guidance. This episode examines how these newer compounds differ pharmacologically, why they are more dangerous, and how clinicians can recognize and respond to kratom-related harms. Listeners will gain practical strategies for identifying kratom use disorder, managing withdrawal, and having informed, non-stigmatizing conversations with patients as these products continue to emerge and change.
Educational Objectives:
- Identify key pharmacological differences between traditional kratom leaf and synthetic forms (7-OH, pseudo) and their implications for increased potency, dependence risk, and clinical presentation.
- Analyze case studies and survey data to apply evidence-informed withdrawal management protocols for semi-synthetic kratom products in various practice settings, considering the lack of controlled trials.
- Apply evidence-informed withdrawal management strategies, including use of buprenorphine, adapted from case studies and national survey themes.
- Demonstrate patient-centered communication approaches to discuss kratom risks, reduce stigma, and develop community-facing materials.
- Evaluate local barriers and regulatory challenges in kratom regulation/bans while prioritizing patient safety and treatment access.